
Mylocar 60mg Injection
Marketer
BDR Pharmaceuticals Internationals Pvt
Salt Composition
Carfilzomib (60mg)
Overview Mylocar 60mg Injection
Carfilzomib 60mg injection treats multiple myeloma by inhibiting or reducing the proliferation of cancerous cells. Administration is strictly via injection by a qualified healthcare provider. Dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Adhere precisely to your doctor's prescribed regimen; improper use or overdosage can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue use only under medical supervision. Common side effects include tiredness, vomiting, and elevated temperature. This medication can lower blood cell counts (red and white blood cells), increasing infection risk. Report fever, chills, musculoskeletal pain, facial flushing/edema, or chest pain immediately. Maintain adequate hydration during treatment. Prior to commencing treatment, inform your doctor of any pre-existing cardiac, hepatic, or renal conditions, or concurrent use of antimicrobial agents. Interactions with other medications are possible; disclose all medications to your healthcare team. This medication is contraindicated during pregnancy and lactation; reliable contraception is crucial for both partners throughout the treatment period.
Uses of Mylocar 60mg Injection
Plasma cell malignancy
Major Benefits of Mylocar 60mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Mylocar 60mg Injection:
- Fatigue
- Anemia (low number of red blood cells)
- Nausea
- Low blood platelets
- Fever
How to use Mylocar 60mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Mylocar 60mg Injection works:
Mylocar 60mg injection is an anticancer agent that inhibits the cellular degradation of proteins. This protein accumulation within cancer cells ultimately triggers their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Mylocar 60mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Mylocar 60mg Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use justifiable if the potential benefits outweigh the known hazards. Seek medical advice before using this medication.
Breast feedingUNSAFE
Administering Mylocar 60mg Injection while breastfeeding is contraindicated. Evidence indicates potential harm to the infant from this medication.
DrivingUNSAFE
Administering Mylocar 60mg Injection can induce drowsiness, blurred vision, and dizziness. Driving is inadvisable if these effects manifest.
KidneyCAUTION
Individuals with impaired kidney function should use Mylocar 60mg Injection with care. Dosage modification of Mylocar 60mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Administering Mylocar 60mg Injection to individuals with hepatic impairment requires careful consideration. Dosage modification for Mylocar 60mg Injection might be necessary. Physician consultation is recommended.
What if you forget to take Mylocar 60mg Injection :
NA
Facts to Know About Mylocar 60mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Epoxomicin Analog |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | Proteasome inhibitor drug |
